Routine HIV testing in Botswana: a population-based study on attitudes, practices, and human rights concerns. by Weiser, Sheri D et al.
UCSF
UC San Francisco Previously Published Works
Title
Routine HIV testing in Botswana: a population-based study on attitudes, practices, and 
human rights concerns.
Permalink
https://escholarship.org/uc/item/3n28b550
Journal
PLoS medicine, 3(7)
ISSN
1549-1277
Authors
Weiser, Sheri D
Heisler, Michele
Leiter, Karen
et al.
Publication Date
2006-07-01
DOI
10.1371/journal.pmed.0030261
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Routine HIV Testing in Botswana:
A Population-Based Study on Attitudes,
Practices, and Human Rights Concerns
Sheri D. Weiser
1,2,3*
, Michele Heisler
1,4
, Karen Leiter
1
, Fiona Percy-de Korte
1
, Sheila Tlou
5
, Sonya DeMonner
1
,
Nthabiseng Phaladze
5
, David R. Bangsberg
3,6
, Vincent Iacopino
1,7
1 Physicians for Human Rights, Cambridge, Massachusetts, United States of America, 2 Center for AIDS Prevention Studies, University of California San Francisco, San
Francisco, California, United States of America, 3 Epidemiology and Prevention Interventions (EPI) Center, Division of Infectious Diseases, San Francisco General Hospital,
University of California San Francisco, San Francisco, California, United States of America, 4 Veterans Affairs Ann Arbor Health System and Department of Internal Medicine,
University of Michigan School of Medicine, Ann Arbor, Michigan, United States of America, 5 Department of Nursing, University of Botswana, Gaborone, Botswana,
6 Positive Health Program, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America, 7 Department of
Medicine, University of Minnesota, Minneapolis, Minnesota, United States of America
Funding: This study was funded by
Physicians for Human Rights and the
Tides Foundation. SDW was funded
by National Institutes of Health grant
T32 MH19105. DRB was funded by
NIH grant K-24 AA015287 and The
Doris Duke Charitable
Foundation.The funders had no role
in study design, data collection and
analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors
have declared that no competing
interests exist.
Academic Editor: Joep Lange,
University of Amsterdam,
Netherlands
Citation: Weiser SD, Heisler M, Leiter
K, Percy-de Korte F, Tlou S, et al.
(2006) Routine HIV testing in
Botswana: A population-based study
on attitudes, practices, and human
rights concerns. PLoS Med 3(7):
e261. DOI: 10.1371/journal.pmed.
0030261
Received: September 26, 2005
Accepted: April 13, 2006
Published: July 18, 2006
DOI:
10.1371/journal.pmed.0030261
Copyright:  2006 Weiser et al. This
is an open-access article distributed
under the terms of the Creative
Commons Attribution License, which
permits unrestricted use,
distribution, and reproduction in any
medium, provided the original
author and source are credited.
Abbreviations: ARV, antiretroviral;
ART, antiretroviral treatment; PLWA,
people living with HIV and AIDS;
VCT, voluntary counseling and
testing
* To whom correspondence should
be addressed. E-mail: Sheri.Weiser@
ucsf.edu
A B S T R A C T
Background
The Botswana government recently implemented a policy of routine or ‘‘opt-out’’ HIV testing
in response to the high prevalence of HIV infection, estimated at 37% of adults.
Methods and Findings
We conducted a cross-sectional, population-based study of 1,268 adults from five districts in
Botswana to assess knowledge of and attitudes toward routine testing, correlates of HIV
testing, and barriers and facilitators to testing, 11 months after the introduction of this policy.
Most participants (81%) reported being extremely or very much in favor of routine testing. The
majority believed that this policy would decrease barriers to testing (89%), HIV-related stigma
(60%), and violence toward women (55%), and would increase access to antiretroviral
treatment (93%). At the same time, 43% of participants believed that routine testing would
lead people to avoid going to the doctor for fear of testing, and 14% believed that this policy
could increase gender-based violence related to testing. The prevalence of self-reported HIV
testing was 48%. Adjusted correlates of testing included female gender (AOR ¼ 1.5, 95% CI ¼
1.1–1.9), higher education (AOR¼2.0, 95% CI¼1.5–2.7), more frequent healthcare visits (AOR¼
1.9, 95% CI ¼ 1.3–2.7), perceived access to HIV testing (AOR ¼ 1.6, 95% CI ¼ 1.1–2.5), and
inconsistent condom use (AOR¼ 1.6, 95% CI¼ 1.2–2.1). Individuals with stigmatizing attitudes
toward people living with HIV and AIDS were less likely to have been tested for HIV/AIDS (AOR
¼ 0.7, 95% CI¼ 0.5–0.9) or to have heard of routine testing (AOR¼ 0.59, 95% CI¼ 0.45–0.76).
While experiences with voluntary and routine testing overall were positive, 68% felt that they
could not refuse the HIV test. Key barriers to testing included fear of learning one’s status
(49%), lack of perceived HIV risk (43%), and fear of having to change sexual practices with a
positive HIV test (33%).
Conclusions
Routine testing appears to be widely supported and may reduce barriers to testing in
Botswana. As routine testing is adopted elsewhere, measures should be implemented to assure
true informed consent and human rights safeguards, including protection from HIV-related
discrimination and protection of women against partner violence related to testing.
The Editors’ Summary of this article follows the references.
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Introduction
There has been widespread concern about the slow uptake
of voluntary counseling and testing (VCT) in many parts of
sub-Saharan Africa [1,2]. VCT is a cornerstone of cost-
effective HIV prevention and linkage to expanding HIV
treatment in low-resource settings [3,4]. Some of the most
significant barriers to HIV testing identified in sub-Saharan
Africa include lack of access to VCT and to high quality
clinical services, lack of access to antiretroviral (ARV)
therapy, and HIV-related stigma [1,5,6].
With a seroprevalence of 37% of adults ages 15–49 [7,8],
Botswana established universal access to antiretroviral treat-
ment (ART) beginning in 2002 for all patients with CD4
counts less than 200 or with an AIDS-defining illness [9–11].
By January 2004, however, only 17,500 patients were enrolled
in the Botswana National Treatment Program out of an
estimated 110,000 eligible individuals [9]. Slow enrollment in
HIV treatment was thought to be due in part to under-
utilization of HIV testing [9,11,12]; by mid-2003, only 70,000
tests in total had been performed in Botswana out of a
population of 1.7 million [13]. HIV stigma was identified by
government and press sources as one possible impediment to
HIV testing and hence to the success of the new ART
program, in that individuals may avoid testing and treatment
facilities to avoid potential stigma and discrimination
[8,11,13]. We previously reported that social stigma and fear
of positive test results significantly delayed testing among a
group of patients treated in the private sector in 2000 [14].
In an attempt to increase the uptake of HIV testing and
ART, the Botswana government introduced the policy of
routine HIV testing in early 2004, whereby nearly all patients
would be tested as a routine part of medical visits unless they
explicitly refused [13,15]. While this approach to testing is
provider-initiated, all patients should receive essential in-
formation about HIV testing and be informed of their right to
refuse. In addition, there is typically greater emphasis on post-
test compared with pre-test counseling [16]. Studies in
resource-rich settings have shown that routine HIV testing
can be cost-effective and life-saving, both by increasing the life
expectancy of individuals with HIV and by reducing the
annual HIV transmission rate [17–21]. In June 2004, as part of
a change in testing policy recommendations, UNAIDS and the
World Health Organization recommended the routine offer
of HIV testing by healthcare providers in a wide range of
clinical encounters based in part on the Botswana experience
[22,23]. The goal of routine testing is to increase the
proportion of individuals aware of their status, and thereby
reduce ‘‘HIV exceptionalism,’’ lessen HIV-related stigma, and
provide more people access to life-saving therapy [16,24].
While provider-initiated approaches to testing are gaining
popularity, there have been concerns that routine testing
policies are potentially coercive, that counseling will no longer
be practiced, that people may be dissuaded from visiting their
doctors for fear of being tested, and that this policy may
increase testing-related partner violence [15,25–27].
As routine testing is increasingly being recommended as an
option in other countries [17, 18,28–30], it is important to
improve our understanding of the consequences and specific
human rights concerns associated with implementation of this
policy in Botswana.We therefore assessed: 1) knowledge of and
attitudes toward routine testing in Botswana with a focus on
human rights concerns associated with this policy; 2) factors
associated with whether respondents had heard of routine
testing, and with positive attitudes toward this policy; and 3)
the prevalence and correlates of HIV testing, barriers and
facilitators to testing, and reported experiences with testing 11
months after the introduction of routine testing in Botswana.
Methods
In November and December 2004, we conducted a cross-
sectional study using structured survey instruments among a
probability sample of 1,268 adults selected from the five
districts of Botswana with the highest number of HIV-
infected individuals. These districts included Gaborone,
Kweneng East, Francistown, Serowe/Palapye, and Tutume,
and cover a population of 725,000 out of a total population of
1.7 million individuals in Botswana. We used a stratified two-
stage probability sample design for the selection of the
population-based sample with the assistance of the Central
Statistics Office at the Ministry of Finance and Development
Planning in Botswana. In the first stage of sampling, 89
enumeration areas were selected with probability propor-
tional to measures of size, where measures of size are the
number of households in the enumeration area as defined by
the 2001 Population and Housing Census. At the second stage
of sampling, households were systematically selected in each
enumeration area by trained field researchers under the
guidance of field supervisors. With a target sample of 1,200
households, and 15% over-sampling for an anticipated 85%
response rate, 1,433 households were selected. Within each
household, random number tables were used to select one
adult member who met our inclusion criteria, and up to two
repeat visits were made.
Participants were excluded if they were older than 49 or
younger than 18 years old, if they had cognitive disabilities, or
if there was inadequate privacy to conduct the interviews.
The 45- to 60-minute survey was conducted in either English
or Setswana in a private setting, and written consent was
obtained from all study participants. Our structured survey
instrument and consent forms were pilot-tested among 20
individuals from Gaborone, and then translated into Set-
swana and back-translated into English. All study procedures
were approved by the Human Subjects Committee at the
University of California San Francisco (San Francisco,
California, United States), as well as by the Botswana Ministry
of Health Research and Development Committee.
Measures
Domains of inquiry for our 234-item survey (Protocol S1)
included demographics, HIV knowledge, experiences with
HIV testing, barriers and facilitators to HIV testing, attitudes
toward routine testing, HIV risk behaviors, HIV-related
stigma, depression, beliefs about gender roles and gender
discrimination, and measures of healthcare access and
utilization. Based on an extensive literature review [2,6,31–
37] and discussions with key informants, we developed a
conceptual model that guided the selection of variables for
our multivariate model for correlates of testing, as shown in
Figure 1. Relevant variables are explained below.
Knowledge of and attitudes toward routine testing.
Participants were asked whether they had heard of routine
testing and were given a detailed explanation of this policy
PLoS Medicine | www.plosmedicine.org July 2006 | Volume 3 | Issue 7 | e2611014
Routine HIV Testing in Botswana
(see Table 1). Participants then indicated the extent to which
they are in favor of routine testing and whether they think
this policy affects HIV-related stigma, barriers to testing,
violence against women related to testing, and uptake of
ARVs. From questions assessing attitudes toward routine
testing (Table 1), we constructed an ordinal outcome of
positive attitudes toward this policy. Participants were
categorized as having zero to one, two, three, or four positive
views toward routine testing. (See Tables 1 and 2 for specific
items.)
HIV testing. Participants were asked whether they had ever
been tested for HIV (by either VCT or routine testing). If so,
they were asked detailed questions about their experiences
with pre-test and post-test counseling, confidentiality, facil-
itators to testing, and personal repercussions of testing. If
not, they were asked a series of questions related to barriers
to testing adapted from the CDC HIV Testing Instrument,
version 9.00, and about their intention to be tested within the
next six months. HIV status was not asked in order to
maximize response rate and hence the generalizability of the
population-based sample.
HIV-related stigma. Respondents were asked seven ques-
tions representing potential stigmatizing attitudes adapted
from the UNAIDS general population survey and the
Department of Health Services AIDS module, which have
been used successfully in previous studies in Botswana [38].
Anyone who reported a discriminatory attitude on any of
four principal questions was registered as having stigmatizing
attitudes per the UNAIDS scoring system. Since participants
may not always openly endorse stigmatizing views toward
people living with HIV and AIDS (PLWA) due to social
desirability bias, as an additional measure of stigma, we also
asked individuals to project the type of responses they would
anticipate from others if they were to test positive for HIV
and divulge their status to others. We converted this
information to a nine-item index on ‘‘projected HIV stigma’’
with higher scores associated with a greater number of
reported adverse social consequences associated with testing
positive. This index had high internal reliability with a
Cronbach alpha of 0.77.
HIV knowledge. Participants were asked 15 questions
about their knowledge of HIV transmission and prevention,
based on questions modified from the UNAIDS General
Population Survey and the Department of Health Services
AIDS module. Using the UNAIDS knowledge indicator
scoring system, individuals were scored as having HIV
knowledge if they correctly identified the two most common
modes of HIV prevention in Botswana.
Figure 1. Hypothesized Model for Predictors of Testing
DOI: 10.1371/journal.pmed.0030261.g001
Table 1. Attitudes toward Routine Testing
Question Answer n (Total n) Percent
Have heard of routine testinga Yes 688 (1,266) 53.7
In favor or not of routine testingb Very much or extremely in favor or routine testing 1,014 (1,251) 81.0
Somewhat in favor of routine testing 105 (1,251) 8.4
Not really or not at all in favor of routine testing 132 (1,251) 10.6
Specific attitudes toward routine testing Agree that routine testing helps people get access to ART 1,162 (1,250) 93.0
Agree that routine testing makes it easier for people to get tested 1,120 (1,263) 88.7
Agree that routine testing results in less discrimination (bad treatment)
of HIV-positive people
761 (1,259) 60.4
Agree that routine testing leads to less violence against women 685 (1,256) 54.5
Agree that routine testing will cause people to avoid seeing doctor
or nurse for fear of being tested
541 (1,256) 43.1
Agree that routine testing leads to more violence against women 174 (1,229) 13.8
Agree that routine testing makes it harder for people to get tested 117 (1,246) 9.3
aThe information on routine testing that was provided to respondents was derived from the guidelines to routine testing distributed to hospitals from the Ministry of Health. According to
the guidelines, the indications for routine testing are: a) all patients presenting to clinics with clinical signs and/or symptoms of HIV; b) pregnant women attending antenatal clinics; c)
patients with STDs; d) all patients ages 16 and over visiting health facilities who are sexually active; and e) any healthy individual going for a general medical exam. Repeat routine testing
should be offered once a year and/or upon the individual’s request. Health providers should give adequate information to patients to enable him/her to give informed consent, but
patients are not typically offered in-depth pre-test counseling. All patients should be given post-test counseling. Patients can choose either a rapid test or standard ELIZA test.
bParticipants were asked ‘‘Now that you know what routine testing means, to what extent are you in favor of routine testing?’’ Response options include ‘‘not at all,’’ ‘‘not really,’’
‘‘somewhat,’’ ‘‘very much,’’ ‘‘extremely.’’
DOI: 10.1371/journal.pmed.0030261.t001
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Depression. As depression is known to impede access to
care and to worsen HIV outcomes in Western settings, we
included depression in our analysis [39–41]. Symptoms of
depression were measured using the 15-item Hopkins
Symptom Checklist for Depression [42] which has been
validated previously in locations in Africa and elsewhere [43].
Analysis
We used standard procedures for data entry and quality
control. All data were analyzed with STATA statistical
software. Outcomes of interest included: a) having heard
of routine testing; b) number of positive attitudes toward
routine testing (categorized as an ordinal variable consisting
of the following categories: zero to one, two, three, and four
positive statements about routine testing); c) self-reported
HIV testing (by either VCT or routine testing); d) having
been tested under routine testing; and e) planning to test
within the next six months (among people who had not
tested).
The following covariates were included in our analyses: 1)
age (continuous); 2) sex; 3) income (population mean,
,population mean); 4) education (high school, ,high
school); 5) residence type (rural, urban, urban village); 6)
marital status (married, living with partner, other); 7) knowl-
edge surrounding HIV/AIDS; 8) HIV-related stigma; 9)
symptoms of depression (dichotomous variable); 10) fre-
quency of visits to a medical provider (,once/year, 1–2 times/
year, 3 times/year); 11) perceived access to good quality
medical clinics; 12) access to ARV therapy in the respondent’s
community; 13) access to HIV testing sites; 14) projected HIV
stigma (continuous index); 15) history of not being consis-
tently treated with respect by health providers; 16) health
status (very good or good versus fair or poor); and 17) history
of inconsistent condom use over the past year.
We used descriptive statistics to examine sample character-
istics and experiences with and attitudes toward testing. We
then conducted univariate and multivariate logistic regres-
sion analyses to explore the independent association of each
covariate with having heard of routine testing, having had a
prior HIV test, having been tested for HIV by routine testing,
and planning to test for HIV among those not tested. We used
ordinal logistic regression to assess factors associated with
number of positive attitudes toward routine testing. All
variables from our conceptual model were included in our
final multivariate models. Regression diagnostic procedures
yielded no evidence of multi-collinearity or overly influential
outliers in any of the models. No variable had more than 3%
missing data.
Results
Description of Study Population
1,268 (89%) respondents completed the survey. Among 165
non-respondents, 46 (28%) were unavailable after two repeat
visits, 78 (47%) refused or did not meet criteria, and 41 (25%)
were unable to complete the interview. Demographic and
behavioral characteristics of the study population are shown
in Table 3.
Knowledge of and Attitudes toward Routine Testing
Fifty-four percent of respondents had heard of routine
testing before the survey interview (Table 1). After adjusting
for all independent variables (see Figure 1), higher education,
higher income, being married, having better health, and
having more frequent medical visits were each associated with
higher odds of having heard of routine testing (Table 2,
column 2). Respondents who reported stigmatizing attitudes
toward PLWA had lower odds of having heard of routine
testing (AOR¼ 0.59, 95% CI¼ 0.45–0.76), as did respondents
with more fears of being stigmatized if they tested positive,
people in rural areas, and people who reported inconsistent
condom use.
Table 2. Respondent Characteristics Associated with Having
Heard of Routine Testing and with Positive Attitudes Toward
Routine Testing in Multivariate Analyses (n ¼ 1,168)
Independent Variables Dependent Variable
Have Heard of
Routine Testing
Adjusted Odds
Ratios (95% CIs)
Positive Attitudes
Toward Routine
Testing Beta
Coefficient
(p-Value)a
Female gender 1.20 (0.92–1.58) 0.35 (0.002)
High school or more education 1.81 (1.35–2.42) 0.03 (0.80)
Average monthly household
income . 1,000 pula
1.54 (1.16–2.04) 0.13 (0.31)
Unmarried, not living with
sexual partner
Reference group Reference group
Unmarried, living with sexual
partner
1.21 (0.88–1.68) 0.07 (0.61)
Married 1.53 (1.00–2.35) 0.07 (0.70)
Urban residence Reference group Reference group
Urban village residence 0.88 (0.65–1.20) 0.12 (0.38)
Rural residence 0.57 (0.41–0.80) 0.11 (0.43)
Self-reported health status:
fair or poor
0.62 (0.46–0.83) 0.18 (0.16)
Frequency of visits to medical
doctor: ,once/year
Reference group Reference group
Frequency of visits to medical
doctor: 1–2 times/year
2.09 (1.48–2.94) 0.30 (0.04)
Frequency of visits to medical
doctor: 3 times/year
2.14 (1.48–3.09) 0.15 (0.34)
Stigmatizing attitudes toward
PLWAb
0.59 (0.45–0.76) 0.004 (0.97)
Projected HIV stigmac 0.93 (0.87–0.99) 0.09 (0.002)
Inconsistent condom use over
the past 12 months
0.74 (0.56–0.98) 0.31 (0.008)
Multivariate logistic regression was used to assess adjusted odds of having heard of
routine HIV testing. Ordinal logistic regression was used to assess respondent character-
istics associated with holding more positive views of routine testing (zero to one, two,
three, or four views). All models were also adjusted for age, depressive symptoms,
perceived access to high quality health care, perceived access to HIV testing, perceived
access to HIV treatment in or near participant’s village, prior poor experiences with
healthcare providers, and good knowledge of HIV/AIDS as assessed by the UNAIDS
knowledge indicator.
aVariable was constructed by four items indicating positive attitudes toward routine
testing (also displayed in Table 1). These include a belief that routine testing leads to a)
less discrimination of people who are HIV-positive, b) less violence toward women, c)
fewer barriers to testing, and d) increased access to ARVs. Participants were scored as
having zero to one, two, three, or four positive views toward routine testing.
bPeople were coded as having stigmatizing attitudes if they reported having stigmatizing
views on any of four principal questions related to AIDS stigma as per the UNAIDS General
Population Survey.
cThis continuous scale with a possible range from zero to nine, was created from a series
of nine questions related to the type of stigma and discrimination respondents feared
that they would experience if they were to test positive for HIV and disclose their status to
others. Higher scores are consistent with projections of greater levels of stigma and
discrimination.
DOI: 10.1371/journal.pmed.0030261.t002
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Attitudes toward Routine Testing
Although approximately half of respondents had heard of
routine testing before the interview, a majority endorsed
positive views toward routine testing after the policy was
explained (Table 1). Eighty-one percent were ‘‘very much’’ or
‘‘extremely’’ in favor of routine testing. A majority agreed
that routine testing results in decreased discrimination of
HIV-positive people (60%), leads to decreased violence
against women (55%), and makes it easier for people to get
tested (89%) and to gain access to ART (93%). On the other
hand, 43% believed that routine testing would cause people
to avoid seeing their health provider for fear of being tested,
and 14% thought that routine testing would lead to more
violence against women. There were fewer than 2% mutually
incompatible response pairs in each of our questions on
routine testing.
In ordinal logistic regression analyses, with number of
positive views toward routine testing as the outcome variable
(Table 2, column 3), those with more fears of being
stigmatized themselves if they tested positive for HIV had
significantly fewer positive views than those without such
fears. Similarly, those who reported unsafe sexual practices
had fewer positive attitudes.
Prevalence and Correlates of Having Been Tested for HIV
Overall, 605 respondents (48%) reported that they had
been tested for HIV. The proportion tested according to
demographic and behavioral attributes are shown in Table 4.
Factors associated with having been tested in unadjusted
analyses included: older age, female gender, higher education,
higher income, self-reported excellent or good health status,
more frequent medical visits, access to good healthcare,
access to HIV testing, being treated with respect consistently
by health providers, lack of stigmatizing attitudes toward
PLWA, and consistent condom use (Table 4). In adjusted
analyses, associations remained among all these covariates
and HIV testing except for older age, higher income, and
being treated with respect consistently by health providers.
Fifteen percent of tested respondents reported having
been tested by routine testing. In a multivariate logistic
regression model with being tested by routine testing as the
dependent outcome, and including all covariates listed in
Figure 1, the only independent correlates of getting routine
testing were being married (AOR¼ 2.67, CI¼ 1.29–5.53) and
seeing the medical provider more than three times per year
(AOR ¼ 2.95, CI ¼ 1.41–6.20). In addition, people who held
stigmatizing attitudes toward PLWA were significantly less
likely to get routine testing (AOR ¼ 0.52, CI ¼ 0.32–0.84).
Experiences with Testing
Among those tested, 54%were tested atVCT centers, 26%at
public hospitals, and the rest were tested in outpatient clinics
or private hospitals. Sixty-two percent of participants who had
undergone testing reported that they last tested in 2004 (after
the introduction of routine testing). Almost all respondents
who had been tested reported that they made the decision on
their own to get tested (93%); however, 68% of participants
believed that they could not refuse the HIV test whether or not
they hadmade the initial decision to test. Ninety-eight percent
reported no ill treatment related to testing, and an equal
proportion claimed that they did not regret getting tested.
Most participants had obtained the results of their tests (94%)
and reported that confidentiality had been strictly maintained
at the testing centers (95%). Nearly all participants (99%)
denied that their partner had hit or threatened them for being
tested. Ninety-six percent reported receiving pre-testing
counseling, 90% reported receiving post-testing counseling,
and 92% reported that their experience with testing led them
to encourage others to undergo testing. Individuals who tested
by VCT reported pre-test counseling more frequently than
those who tested by routine testing (97% versus 93%, p¼0.04)
and less poor treatment from others related to testing (2%
versus 6%, p¼ 0.03).
Barriers and Facilitators to Testing
Table 5 presents reported impediments to HIV testing
among respondents who had not been tested (n ¼ 658).
Participants indicated whether any of the listed factors served
Table 3. Baseline Characteristics of Respondents (n ¼ 1,268)
Characteristic Total n n (Percent) or
Mean 6 SD
Age (years) 1,259 8.3 (9.6)
Female gender 1,267 654 (51.6)
Married 1,266 242 (19.1)
Unmarried, living with partner 1,266 340 (26.9)
Unmarried, not living with sexual partner 1,266 684 (54.0)
Education  high school 1,257 684 (54.4)
Average monthly household income
. 1,000 pula (US$200–250)
1,261 693 (55.0)
Urban residence 1,268 557 (43.9)
Urban village residence 1,268 375 (29.6)
Rural residence 1,268 336 (26.5)
Depressive symptomsa 1,268 366 (28.9)
Problems gaining access to food 1,264 297 (23.5)
Perceived access to good quality medical services 1,247 1,026 (82.3)
Self-reported health status: excellent or very good 1,262 892 (70.7)
Self-reported health status: fair or poor 1,262 370 (29.3)
Frequency of visits to medical doctor: ,once/year 1,265 278 (22.0)
Frequency of visits to medical doctor: 1–2 times/year 1,265 565 (44.7)
Frequency of visits to medical doctor: 3 times/year 1,265 422 (33.4)
History of having been treated without
respect by health providers
1,258 201 (16.0)
Access to HIV testing: yes 1,267 1,063 (83.9)
Access to HIV testing: no 1,267 192 (15.1)
Access to HIV testing: don’t know 1,267 12 (1.0)
Access to ARVs in or near village: yes 1,268 979 (77.2)
Access to ARVs in or near village: no 1,268 183 (14.4)
Access to ARVs in or near village: don’t know 1,268 106 (8.4)
Stigmatizing attitudes toward PLWAb 1,268 668 (52.7)
Projected HIV stigma (mean 6 SD)c 1,268 1.85 (1.9)
Correct HIV prevention knowledged 1,266 1,079 (85.2)
Inconsistent condom use over past 12 months 1,231 473 (38.4)
There was less than 3% missing data on any variable.
aScreening positive for depression according to the Hopkins Symptom Checklist for
Depression, which has been validated in a number of international settings in Africa and
elsewhere.
bPeople were coded as having stigmatizing attitudes if they reported having stigmatizing
views on any of four principal questions related to AIDS stigma as per the UNAIDS General
Population Survey.
cThis continuous scale with a possible range from zero to nine was created from a series
of nine questions related to the type of stigma and discrimination respondents feared
that they would experience if they were to test positive for HIV and disclose their status to
others. Higher scores are consistent with projections of greater levels of stigma and
discrimination.
dPeople were coded as having correct knowledge if they agreed with the two most
common modes of HIV prevention in Botswana as assessed by the UNAIDS knowledge
indicator (UNAIDS General Population Survey).
DOI: 10.1371/journal.pmed.0030261.t003
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as a barrier for them; they could agree with multiple possible
responses. Almost half agreed that a key barrier to testing was
that they were ‘‘afraid to know’’ if they were HIV-positive.
Forty-three percent reported that they had no reason to
believe that they were infected, and 33% did not test because
testing positive would force them to stop some of their sexual
practices. There were several significant gender differences in
the cited barriers to testing. Women were significantly more
likely than men to report lack of permission from their
spouse or partner (10% versus 3%, p , 0.01). Men were more
likely to cite frequent migration (25% versus 15%, p ¼ 0.01),
not wanting to change sexual practices (39% versus 27%, p ,
0.01), and concerns about lack of social supports if they tested
positive (20% versus 12%, p , 0.01).
Among those who had not been tested, 71% reported that
they intended to be tested in the next six months. The most
commonly cited factors that would facilitate testing included
knowing that they could get treatment for HIV/AIDS (67%),
and being tested with their spouse or main partner (64%). In
a multivariate logistic model assessing planning to test as the
dependent outcome and including all of our hypothesized
correlates of getting tested (Figure 1), respondents with
stigmatizing attitudes had significantly lower odds of plan-
ning to get tested than those without stigmatizing attitudes
(AOR¼ 0.44, 95% CI¼ 0.28–0.70). Respondents who reported
unprotected sex had significantly higher odds of planning to
test (AOR ¼ 2.21, 95% CI ¼ 1.42–3.44). The only other
respondent characteristics associated with planning to test
were urban location and self-reported very good or good
health.
The most common facilitating factors among those tested
were TV or radio messages (69%), knowing that treatment
was available (65%), and knowing that the test results would
be confidential (64%) (Table 6). Men were significantly more
likely than women to list treatment availability (74% versus
58%, p , 0.01), advice from family or friends (44% versus
Table 4. Unadjusted and Adjusted Odds of Having Been Tested for HIV (n¼ 1,164)
Independent Variables Unadjusted Adjusted for Other
Respondent Characteristics
Percent
Tested
OR (95% CI) AOR (95% CI)
Age continuous: þ10 years – 1.27 (1.12–1.44) 1.11 (0.94–1.31)
Male gender 44 Reference group Reference group
Female gender 52 1.36 (1.09–1.70) 1.47 (1.13–1.91)
Education , high school 40 Reference group Reference group
Education  high school 55 1.86 (1.49–2.33) 2.02 (1.51–2.71)
Average monthly household income 1,000 pula or less 42 Reference group Reference group
Average monthly household income . 1,000 pula 53 1.56 (1.25–1.96) 0.89 (0.67–1.18)
Unmarried, not living with sexual partner 42 Reference group Reference group
Unmarried, living with sexual partner 51 1.46 (1.12–1.90) 1.36 (0.99–1.87)
Married 61 2.15 (1.59–2.90) 1.49 (0.98–2.25)
Urban residence 50 Reference group Reference group
Urban village residence 51 1.01 (0.78–1.32) 0.98 (0.72–1.32)
Rural residence 41 0.69(0.53–0.91) 0.81 (0.59–1.13)
Self-reported health status: excellent or very good 52 Reference group Reference group
Self-reported health status: fair or poor 38 0.58(0.45–0.74) 0.70 (0.53–0.94)
Frequency of visits to medical doctor: ,once a year 35 Reference group Reference group
Frequency of visits to medical doctor: 1–2 times/year 47 1.65 (1.23–2.22) 1.35 (0.96–1.90)
Frequency of visits to medical doctor: 3 times/year 58 2.56 (1.87–3.51) 1.90 (1.31–2.74)
Perceived access to good quality medical services: no 28 Reference group Reference group
Perceived access to good quality medical services: yes 53 2.92 (2.12–4.03) 2.93 (2.02–4.23)
History of having been treated without respect by health providers: no 49 Reference group Reference group
History of having been treated without respect by health providers: yes 41 0.71 (0.52–0.96) 1.12 (0.78–1.62)
Access to HIV testing: no 32 Reference group Reference group
Access to HIV testing: yes 51 2.26 (1.63–3.14) 1.64 (1.07–2.52)
Access to HIV testing: don’t know 8 0.20 (0.02–1.55) 0.30 (0.03–2.64)
Access to ARVs in or near village: no 44 Reference group Reference group
Access to ARVs in or near village: yes 51 1.33 (0.97–1.82) 0.73 (0.47–1.13)
Access to ARVs in or near village: don’t know 23 0.368 (0.21–0.63) 0.34 (0.18–0.64)
Stigmatizing attitudes toward PLWAa: no 53 Reference group Reference group
Stigmatizing attitudes toward PLWAa: yes 43 0.68 (0.54–0.85) 0.65 (0.50–0.85)
Projected HIV stigmab: þ1 point on continuous nine-item scale – 0.90 (0.85–0.96) 0.98 (0.92–1.05)
Inconsistent condom use over past 12 months: no 43 Reference group Reference group
Inconsistent condom use over past 12 months: yes 57 1.73 (1.37–2.18) 1.56 (1.18–2.06)
The multivariate logistic model included all the variables listed in the table and also adjusted for depressive symptoms and good knowledge of HIV/AIDS as assessed by the UNAIDS
knowledge indicator (UNAIDS General Population Survey), neither of which were associated in bivariate or multivariate analyses with having ever been tested for HIV.
aPeople were coded as having stigmatizing attitudes if they reported having stigmatizing views on any of four principal questions related to AIDS stigma as per the UNAIDS General
Population Survey.
bThis continuous scale with a possible range from zero to nine, was created from a series of nine questions related to the type of stigma and discrimination respondents feared that they
would experience if they were to test positive for HIV and to disclose their status to others. Higher scores are consistent with projections of greater levels of stigma and discrimination.
DOI: 10.1371/journal.pmed.0030261.t004
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34%, p¼ 0.02), messages from the media (77% versus 63%, p
, 0.01), encouragement or support from someone who had
been tested (55% versus 33%, p, 0.01), and confidentiality of
testing (74% versus 56%, p , 0.01) as factors that influenced
them to get tested. Women were significantly more likely to
report encouragement from prenatal programs (31% versus
13%, p , 0.01) as a facilitator to testing.
Discussion
This is the first study to our knowledge to assess knowledge,
attitudes, and experiences surrounding the new policy of
routine testing in Botswana. We found that 11 months after
the introduction of routine testing in Botswana, there was
widespread support for this policy in a population-based
survey, with 81% of participants reporting that they were
either extremely or very much in favor of routine testing and
an additional 8% reporting that they were somewhat in favor
of this policy. A majority of respondents felt that routine
testing would decrease barriers to testing, HIV-related
stigma, and violence toward women, and would increase
uptake of ARVs through the Botswana National Treatment
Program. These results, in conjunction with data showing a
significant increase in testing and treatment uptake since the
introduction of this policy [9,12,44], suggest that this policy is
beneficial in improving access to testing and life-saving
treatment. Consistent with this, a study of several prenatal
clinics in Botswana found that routine prenatal HIV testing
was associated with a 15% increase in the proportion of
pregnant women undergoing HIV testing between February
and April 2004 (after routine testing was introduced) when
compared with the last few months of 2003 [44]. Figures also
indicate a more than 2-fold increase in treatment enrollment
since the introduction of this policy, with 42,000 individuals
enrolled in treatment as of March 2005 [45].
Evaluating our findings in the context of potential human
rights burdens, we found that few individuals reported
violence (1%), discrimination (2%), or a breach of confiden-
tiality by healthcare workers (5%) associated with VCT or
routine testing. Highlighting some potential problems with
routine testing, 43% believed that routine testing would lead
to avoidance of doctor visits for fear of being tested, and 14%
felt that this policy could lead to increased violence against
women. In addition, approximately two-thirds of participants
who were tested by either routine testing or VCT felt that
they could not refuse the HIV test, suggesting that the
voluntary nature of both routine testing and VCT is not fully
understood. These findings underscore the importance of
implementing HIV testing policies with measures in place to
ensure informed consent, protection of confidentiality, and
protection of women from gender-based violence related to
testing. Careful monitoring and evaluation of Botswana’s
routine testing program will help to ensure that the
significant benefits of this program in terms of linkage to
care and prevention of HIV transmission are not associated
with potential adverse impacts.
Detailed guidelines for the implementation of routine
testing were not introduced until February 2004, and the
training of healthcare practitioners and the development of
training materials were still ongoing in early 2005 [15].
Consequently, at the time of our study, there was still some
confusion surrounding the details of implementation of this
policy, including the extent to which routine testing should
be provided as opt-out (all patients are automatically tested
unless they refuse) or as routine-offer (all patients are offered
a test, and they must provide explicit informed consent). The
current policy has moved toward routine-offer HIV testing in
accordance with the recommendations of WHO and UN-
AIDS; both organizations emphasize that the central princi-
ples of testing should include confidentiality, counseling, and
informed consent [22,24,47]. As counseling has been found to
account for some of the benefits of VCT in terms of reduced
HIV transmission risk behavior [46] and linkage to subse-
quent medical care, reinforcing the importance of counseling
in routine testing programs may help ensure that these
programs help to maximize sexual-risk reduction and access
to care. Additional conditions should be considered when
implementing routine testing policies elsewhere, including
Table 6. Principal Facilitators to Testing among Respondents
Who Had Been Tested (n ¼ 590)
Reason for Testing Number
(Percent)
TV or radio messages 411 (69)
Knew that treatment was available 385 (65)
Knew test results would be confidential 377 (64)
Heard could take test and get results same day 269 (45)
Was encouraged by someone who had been tested 252 (43)
Was worried about a previous sexual contact 240 (41)
Partner, family, or friends advised to have test 229 (38)
Prenatal program advised to have test 136 (23)
Was sick 126 (21)
Doctor/nurse recommended test 90 (15)
It was necessary to donate blood 89 (15)
Respondents could agree with more than one reason.
DOI: 10.1371/journal.pmed.0030261.t006
Table 5. Principal Barriers to Testing among Respondents Who
Had Not Been Tested (n ¼ 664)
Reason Not Tested Number
(Percent)
Afraid to know status 328 (49)
No reason to believe was infected 281 (43)
Testing positive would force them to stop some sexual practices 220 (33)
No testing close to where live or work 145 (22)
Moved around so often, difficult to get tested 134 (20
Worried other people would be told test results without consent 120 (18%)
Worried would not have social supports if positive 107 (16)
Did not trust that the HIV test would give correct result 100 (15)
No access to good quality clinics 96 (15)
Was ashamed to be seen at the testing site 94 (14)
No treatment available if test positive 94 (14)
Fear of discrimination by health providers 70 (11)
Worried about violence from partner related to testing 66 (10)
Other people advised not to test 51(8)
More worried about lack of food 48 (7)
Partner would not allow them to test 42 (6)
Respondents could agree with more than one reason.
DOI: 10.1371/journal.pmed.0030261.t005
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the need to increase human resources and to expand the use
of rapid testing.
Consistent with the documented role of HIV-related stigma
as an impediment to testing in studies in Africa and elsewhere
[6,31,37,48–50], we found that HIV-related stigma was
associated with decreased odds of having been tested for
HIV, of getting routine testing, and of planning to test among
people not previously tested. In addition, respondents with
more stigmatizing views about HIV and a greater number of
fears related to HIV stigma were significantly less likely to
have heard of routine testing after adjusting for possible
confounders, attesting to the association between poor
information and HIV-related stigma. Addressing HIV-related
stigma should comprise an integral part of ongoing HIV
testing programs and policies in Botswana, including meas-
ures to protect people with HIV/AIDS from discrimination in
healthcare, work, and other settings. Policies that target HIV-
related stigma may also prevent a reduction of clinical visits
related to people’s fears of being tested. Increasing testing
and decreasing stigma will likely work together to reinforce
one another, with more testing leading to a reduction in HIV-
related stigma, which in turn will work to further increase
testing. Botswana already has several innovative programs in
place aimed to address stigma directly, including media
campaigns, the public testing of President Festus Mogae and
other national leaders, and the annual ‘‘Miss HIV Stigma
Free’’ competition [11,14]. Additional progress toward stigma
reduction will require a deeper understanding of the
structural dimensions of HIV-related stigma, and the mech-
anisms by which stigma reinforces and generates social
inequalities related to gender, ethnicity, and class [51].
We found a relatively high prevalence of self-reported HIV
testing in Botswana in the era of routine testing, compared
with its neighboring countries. While 48% of our sample
reported having been tested for HIV, results from Zimbabwe
suggest that only 10%–12% of people are aware of their HIV
status [52], and a nationwide community based–survey in
South Africa in 2002 found that only 20% of people aware of
VCT services had been tested for HIV [53]. In addition to the
policy of routine testing, universal access to ARVs and to HIV
testing likely contributes to the relatively high prevalence of
testing in Botswana. Consistent with this, perceived access to
testing was associated with 60% higher odds of having
received an HIV test among respondents in our study, and
the availability of ART was cited as a leading facilitator to
testing. In addition, a national survey from Botswana in 2001
showed that fewer than 20% of individuals ages 15–49 had
ever received an HIV test [54], suggesting a more than 2-fold
increase in testing prevalence since the introduction of both
universal ART access and routine testing. On the other hand,
because over 50% of our sample had not yet been tested, our
results reinforce the fact that availability of testing facilities
and ART, while essential, may not be sufficient to guarantee
HIV testing for many [31].
Study results should be interpreted in the context of a
number of limitations. First, as this study was cross-sectional,
causality cannot be determined from our findings. Second,
while we interviewed individuals from both rural and urban
areas, and covered the five most populated districts in
Botswana, because we did not interview individuals in all
districts of Botswana, our results may not be generalizable to
the entire Botswana population. In addition, Botswana has a
number of unique features that may limit generalizability to
neighboring African countries, such as its relatively high per
capita income, comparatively extensive healthcare infra-
structure, strong donor involvement, and strong government
commitment to combating HIV. Third, as the policy of
routine testing was not yet implemented in a uniform way
across all medical facilities in Botswana, and different
facilities were at different stages of implementation, it was
impossible to conduct a more systematic evaluation of the
impacts of this policy. Moreover, since routine testing is a
relatively new policy in Botswana, only a small proportion of
those tested (15%) had been tested by routine testing at the
time of our study. Finally, self-report can introduce mis-
classification and bias. To maximize validity we did not ask
about HIV status, assured confidentiality and privacy, and
asked survey questions in a culturally sensitive, nonjudgmen-
tal manner. To reduce social desirability bias, interviewers
were not informed of key research hypotheses, and study aims
were presented to participants in general terms.
Concluding Remarks
In the face of a devastating epidemic that has already
infected nearly half of its adult population, the government
of Botswana has taken strong steps to improve access to
testing and to ensure the right to life-sustaining treatment for
all of its citizens. Early evidence of widespread support for
the policy of routine testing in this study holds significant
promise for the prevention and treatment of HIV/AIDS in
Botswana and elsewhere. Concerted efforts to scale up HIV
testing, however, must also be accompanied by appropriate
monitoring of testing practices to ensure that they are
implemented in accordance with international guidelines on
human rights and HIV/AIDS [55,56].
Supporting Information
Protocol S1. Botswana Community Survey
Found at DOI: 10.1371/journal.pmed.0030261.sd001 (338 KB DOC).
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Editors’ Summary
Background. In 2005, there were 5 million new infections with the
human immunodeficiency virus (HIV), and the disease it causes—
acquired immunodeficiency syndrome (AIDS)—killed three million
people. Despite the increased availability of drugs that can fight HIV
(antiretrovirals), the AIDS epidemic continues to grow, particularly in sub-
Saharan Africa. To halt it, more needs to be done to prevent the spread of
HIV. Education about safe sex can help—HIV is most commonly spread
through unprotected sex with an infected partner—but increasing HIV
testing is of paramount importance. Unfortunately, the uptake of
voluntary counseling and testing in sub-Saharan Africa is worryingly
low. Fear of being stigmatized—socially disgraced—and discriminated
against, fears about the positive result itself, and worries about access to
antiretroviral drugs are all putting people off being tested.
Why Was This Study Done? In Botswana, one in three adults is infected
with HIV. Since 2002, antiretroviral drugs have been freely available but
enrollment in the Botswana National Treatment Program during its first
two years was slow, in part due to inadequate uptake of voluntary HIV
testing. Consequently, in early 2004, the government introduced a policy
of routine HIV testing in which all patients are tested for HIV when they
visit their doctor unless they opt out. A major aim of this approach to HIV
testing, which was formally recommended in June 2004 by UNAIDS and
the World Health Organization, is to increase uptake of HIV testing and
treatment, and to reduce HIV-related stigma by treating the HIV test like
any other routine medical procedure. However, there are fears that the
policy could back-fire—people might not visit their doctors, for example,
because they are afraid of being tested and think that they will not be
able to refuse the test. In this study, the researchers investigated
knowledge of and attitudes to routine testing in Botswana to understand
better the consequences of a routine testing policy.
What Did the Researchers Do and Find? The researchers interviewed
adults throughout Botswana about their knowledge of and attitudes to
routine HIV testing 11 months after introduction of the policy. Only half of
the participants had heard of routine testing before being interviewed
but nearly all were in favor of routine testing. More than half thought it
would reduce HIV-related stigma and the violence toward women that is
associated with an HIV-positive status. However, almost half believed that
routine testing might prevent people from going to the doctor because
of fear of testing and a few thought the policy would increase violence
against women. Nearly half of the interviewees had had an HIV test and
the researchers found, for example, that women were more likely to have
been tested thanmen and that people with stigmatizing attitudes toward
people living with HIV and AIDS were less likely to be tested. Fear of
learning one’s HIV status, lack of perceived risk, and fear of having to
change sexual practices if positive all stopped people taking the test.
Finally, although experiences with testing were generally positive,
approximately two-thirds of interviewees who had been tested felt that
it would have been difficult to refuse the test.
What Do These Findings Mean? These results show that there is
widespread support for routine HIV testing in Botswana, a finding
supported by recent increases in treatment uptake. Routine testing, write
the researchers, holds significant promise for the prevention and
treatment of HIV/AIDS in Botswana and elsewhere. In particular,
increasing the number of people tested for HIV may reduce HIV-related
stigma, which should further increase testing and hopefully slow the
spread of HIV. But the results of this study also highlight some areas of
concern. Whenever HIV testing policies are implemented, human rights
must be protected by ensuring that patients have all the information
necessary to make an informed and free decision about being tested, by
providing protection for women against violence related to HIV status,
and by ensuring total confidentiality. Careful monitoring of Botswana’s
program and similar programs will be needed to ensure that these human
rights are fully met, conclude the researchers.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0030261
 US National Institute of Allergy and Infectious Diseases factsheet on HIV
infection and AIDS
 US Department of Health and Human Services information on AIDS
 US Centers for Disease Control and Prevention information on HIV/AIDS
 UNAIDS and World Health Organization 2004 policy statement on HIV
testing
 AVERT, a UK-based charity, provides information about HIV and AIDS in
Botswana
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